Copyright Reports & Markets. All rights reserved.

Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Report 2019

      1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview

      • 1.1 Squamous Non-Small Cell Lung Cancer TherapeuticsProduct Overview
      • 1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Type
        • 1.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Comparison by Types (2014-2025)
        • 1.2.2 BMS-906024
        • 1.2.3 Buparlisib Hydrochloride
        • 1.2.4 FP-1039
        • 1.2.5 Ipilimumab
        • 1.2.6 JNJ-42756493
        • 1.2.7 Lenvatinib
        • 1.2.8 Others
      • 1.3 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Application
        • 1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Comparison by Application (2014-2025)
        • 1.3.1 Research Center
        • 1.3.2 Hospital
        • 1.3.3 Clinic
      • 1.4 Squamous Non-Small Cell Lung Cancer Therapeutics Market by Region
        • 1.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Comparison by Region (2014-2025)
        • 1.4.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 India Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
      • 1.5 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue (2014-2025)
        • 1.5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth Rate (2014-2025)
        • 1.5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2014-2025)

      2 Squamous Non-Small Cell Lung Cancer Therapeutics by Company, Region, Type and Application

      • 2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Competition by Companies
        • 2.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share of Key Companies (2014-2019)
        • 2.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Company (2014-2019)
      • 2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue by Region
        • 2.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Region (2014-2019)
        • 2.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Region (2014-2019)
      • 2.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue by Type
        • 2.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type (2014-2019)
        • 2.3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2014-2019)
      • 2.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales by Application

      3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price

      • 3.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue (2014-2019)
        • 3.1.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019)
        • 3.1.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Rate (2014-2019)
        • 3.1.3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend (2014-2019)
      • 3.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Company
      • 3.3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type
      • 3.4 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Application

      4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price

      • 4.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Value (2014-2019)
        • 4.1.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019)
        • 4.1.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Rate (2014-2019)
        • 4.1.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend (2014-2019)
      • 4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Company
      • 4.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type
      • 4.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Application

      5 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price

      • 5.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue (2014-2019)
        • 5.1.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019)
        • 5.1.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Rate (2014-2019)
        • 5.1.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend (2014-2019)
      • 5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Company
      • 5.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type
      • 5.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Application

      6 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price

      • 6.1 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Value (2014-2019)
        • 6.1.1 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019)
        • 6.1.2 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Rate (2014-2019)
        • 6.1.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend (2014-2019)
      • 6.2 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Company
      • 6.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type
      • 6.4 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Application

      7 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price

      • 7.1 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Value (2014-2019)
        • 7.1.1 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019)
        • 7.1.2 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Rate (2014-2019)
        • 7.1.3 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend (2014-2019)
      • 7.2 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Company
      • 7.3 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type
      • 7.4 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Application

      8 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price

      • 8.1 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Value (2014-2019)
        • 8.1.1 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019)
        • 8.1.2 India Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Rate (2014-2019)
        • 8.1.3 India Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend (2014-2019)
      • 8.2 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Company
      • 8.3 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Type
      • 8.4 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share by Application

      9 Company Profiles and Key Figures in Squamous Non-Small Cell Lung Cancer Therapeutics Business

      • 9.1 Ascenta Therapeutics, Inc.
        • 9.1.1 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.1.4 Main Business and Markets Served
      • 9.2 AstraZeneca Plc
        • 9.2.1 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.2.4 Main Business and Markets Served
      • 9.3 AVEO Pharmaceuticals, Inc.
        • 9.3.1 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.3.4 Main Business and Markets Served
      • 9.4 Bayer AG
        • 9.4.1 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.4.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.4.4 Main Business and Markets Served
      • 9.5 BIND Therapeutics, Inc.
        • 9.5.1 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.5.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.5.4 Main Business and Markets Served
      • 9.6 Boehringer Ingelheim GmbH
        • 9.6.1 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.6.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.6.4 Main Business and Markets Served
      • 9.7 Bristol-Myers Squibb Company
        • 9.7.1 Bristol-Myers Squibb Company Production Sites and Area Served
        • 9.7.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.7.4 Main Business and Markets Served
      • 9.8 Eli Lilly and Company
        • 9.8.1 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.8.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.8.4 Main Business and Markets Served
      • 9.9 F. Hoffmann-La Roche Ltd.
        • 9.9.1 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.9.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.9.4 Main Business and Markets Served
      • 9.10 Five Prime Therapeutics, Inc.
        • 9.10.1 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
        • 9.10.2 Squamous Non-Small Cell Lung Cancer Therapeutics Specification and Application
        • 9.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.10.4 Main Business and Markets Served
      • 9.11 Genentech, Inc.
      • 9.12 Incyte Corporation
      • 9.13 Johnson & Johnson
      • 9.14 MacroGenics, Inc.
      • 9.15 Novartis AG
      • 9.16 Oncogenex Pharmaceuticals, Inc.
      • 9.17 PsiOxus Therapeutics Limited

      10 Squamous Non-Small Cell Lung Cancer Therapeutics Maufacturing Cost Analysis

      • 10.1 Squamous Non-Small Cell Lung Cancer Therapeutics Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Key Raw Materials Price Trend
        • 10.1.3 Key Suppliers of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
      • 10.3 Manufacturing Process Analysis of Squamous Non-Small Cell Lung Cancer Therapeutics
      • 10.4 Squamous Non-Small Cell Lung Cancer Therapeutics Industrial Chain Analysis

      11 Marketing Channel, Distributors and Customers

      • 11.1 Marketing Channel
        • 11.1.1 Direct Marketing
        • 11.1.2 Indirect Marketing
      • 11.2 Squamous Non-Small Cell Lung Cancer Therapeutics Distributors List
      • 11.3 Squamous Non-Small Cell Lung Cancer Therapeutics Customers

      12 Market Dynamics

      • 12.1 Market Trends
      • 12.2 Opportunities
      • 12.3 Market Drivers
      • 12.4 Challenges
      • 12.5 Influence Factors

      13 Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast

      • 13.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue and Price Forecast
        • 13.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Forecast (2019-2025)
        • 13.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Forecast (2019-2025)
        • 13.1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend Forecast (2019-2025)
      • 13.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Region
        • 13.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Forecast by Region (2019-2025)
        • 13.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Growth Forecast by Region (2019-2025)
        • 13.2.3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.6 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.7 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.8 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Growth Forecast (2019-2025)
      • 13.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Type
        • 13.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Forecast by Type (2019-2025)
        • 13.3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Forecast by Type (2019-2025)
        • 13.3.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price Forecast by Type (2019-2025)
      • 13.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Application

      14 Research Findings and Conclusion

        15 Methodology and Data Source

        • 15.1 Methodology/Research Approach
          • 15.1.1 Research Programs/Design
          • 15.1.2 Market Size Estimation
          • 15.1.3 Market Breakdown and Data Triangulation
        • 15.2 Data Source
          • 15.2.1 Secondary Sources
          • 15.2.2 Primary Sources
        • 15.3 Author List

        The global Squamous Non-Small Cell Lung Cancer Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report studies the global Squamous Non-Small Cell Lung Cancer Therapeutics market status and forecast, categorizes the global Squamous Non-Small Cell Lung Cancer Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

        Major manufacturers covered in this report
        Ascenta Therapeutics, Inc.
        AstraZeneca Plc
        AVEO Pharmaceuticals, Inc.
        Bayer AG
        BIND Therapeutics, Inc.
        Boehringer Ingelheim GmbH
        Bristol-Myers Squibb Company
        Eli Lilly and Company
        F. Hoffmann-La Roche Ltd.
        Five Prime Therapeutics, Inc.
        Genentech, Inc.
        Incyte Corporation
        Johnson & Johnson
        MacroGenics, Inc.
        Novartis AG
        Oncogenex Pharmaceuticals, Inc.
        PsiOxus Therapeutics Limited

        In view of regional level, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        BMS-906024
        Buparlisib Hydrochloride
        FP-1039
        Ipilimumab
        JNJ-42756493
        Lenvatinib
        Others

        Segment by Application
        Research Center
        Hospital
        Clinic

        Buy now